Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

Perioperative Prophylactic Antibiotics in 1,250 Orbital Surgeries.

Fay A, Nallasamy N, Allen RC, Bernardini FP, Bilyk JR, Cockerham K, Cruz AA, Devoto M, Dolman PJ, Dutton J, Jordan DR, Kersten R, Kim YD, Lucarelli MJ, McNab AA, Mombaerts I, Mourits M, Nerad J, Perry JD, Rose G, Saeed P, Seah LL, Selva D, Sivak-Callcott J, Strianese D, Verity DH; Orbital Society.

Ophthalmic Plast Reconstr Surg. 2020 Jan 7. doi: 10.1097/IOP.0000000000001565. [Epub ahead of print]

PMID:
31917766
2.

Neuromuscular Diseases of the Newborn.

Fay AJ.

Semin Pediatr Neurol. 2019 Dec;32:100771. doi: 10.1016/j.spen.2019.08.007. Epub 2019 Sep 5.

PMID:
31813523
3.

LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA.

Belot A, Gourbeyre O, Fay A, Palin A, Besson C, Latour C, Hopkins CR, Tidmarsh GF, Coppin H, Roth MP, Ritter MR, Hong CC, Meynard D.

Haematologica. 2019 Dec 5. pii: haematol.2019.236133. doi: 10.3324/haematol.2019.236133. [Epub ahead of print]

4.

Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.

Nassar AH, Hamieh L, Gray KP, Thorner AR, Fay AP, Lasseter KD, Abou Alaiwi S, Nuzzo PV, Flippot R, Krajewski KM, Signoretti S, Choueiri TK, Kwiatkowski DJ.

Mol Cancer Ther. 2020 Feb;19(2):690-696. doi: 10.1158/1535-7163.MCT-19-0642. Epub 2019 Oct 25.

PMID:
31653662
5.

Ocular Adnexal Adenomatoid Sebaceous Gland Hyperplasia: A Clinical and Immunopathologic Analysis in Relation to the Muir-Torre Syndrome.

Jakobiec FA, Cortes Barrantes P, Milman T, Lee NG, Fay A.

Ophthalmic Plast Reconstr Surg. 2020 Jan/Feb;36(1):e6-e12. doi: 10.1097/IOP.0000000000001497.

PMID:
31593035
6.

Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery.

de Cássio Zequi S, da Costa WH, Korkes F, Dos Reis RB, Busato WFS, Matheus WE, da Silva Neto DCV, de Almeida E Paula F, Carvalhal GF, Nogueira L, de Carvalho Fernandes R, Silva AGE, Sasse AD, Fay AP, Jardim DL, Bastos DA, da Rosa DAR, Wierman E, Kater F, Schutz FA, Maluf FC, de Oliveira FNG, Morbeck IAP, Rinck JA, da Trindade KM, Maia MC, Souza VC, Monteiro FSM, Soares A.

Ther Adv Urol. 2019 Sep 9;11:1756287219872324. doi: 10.1177/1756287219872324. eCollection 2019 Jan-Dec. Review.

7.

Evaluation of a pharmacist-led naloxone coprescribing program in primary care.

Cariveau D, Fay AE, Baker D, Fagan EB, Wilson CG.

J Am Pharm Assoc (2003). 2019 Nov - Dec;59(6):867-871. doi: 10.1016/j.japh.2019.07.012. Epub 2019 Aug 26.

PMID:
31466899
8.

Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.

Fay A, Czudnochowski N, Rock JM, Johnson JR, Krogan NJ, Rosenberg O, Glickman MS.

mBio. 2019 Jun 25;10(3). pii: e00850-19. doi: 10.1128/mBio.00850-19.

9.

The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels.

Werutsky G, Maluf FC, Cronemberger EH, Carrera Souza V, Dos Santos Martins SP, Peixoto F, Smaletz O, Schutz F, Herchenhorn D, Santos T, Mavignier Carcano F, Queiroz Muniz D, Nunes Filho PRS, Zaffaroni F, Barrios C, Fay A.

BMC Cancer. 2019 May 23;19(1):487. doi: 10.1186/s12885-019-5709-y.

10.

Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?

Fay AP, Antonarakis ES.

Ann Transl Med. 2019 Mar;7(Suppl 1):S7. doi: 10.21037/atm.2019.01.37. No abstract available.

11.

Hyaluronic Acid Gel Biodegradation After Intrapalpebral and Intraorbital Injection in Experimental Study.

Sheptulin V, Fedorov A, Prause J, Fay A, Grusha Y.

Ophthalmic Plast Reconstr Surg. 2019 Nov/Dec;35(6):558-561. doi: 10.1097/IOP.0000000000001374.

PMID:
30925540
12.

Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition.

Ballinger E, Mosior J, Hartman T, Burns-Huang K, Gold B, Morris R, Goullieux L, Blanc I, Vaubourgeix J, Lagrange S, Fraisse L, Sans S, Couturier C, Bacqué E, Rhee K, Scarry SM, Aubé J, Yang G, Ouerfelli O, Schnappinger D, Ioerger TR, Engelhart CA, McConnell JA, McAulay K, Fay A, Roubert C, Sacchettini J, Nathan C.

Science. 2019 Feb 1;363(6426). pii: eaau8959. doi: 10.1126/science.aau8959. Erratum in: Science. 2019 Jun 21;364(6446):.

13.

Immunohistochemical analysis of tissue factor expression in gastric carcinoma: correlations with prognosis and survival.

Toneto MG, Depaula PL, Debon L, Tertuliano B, Silva VD, Baldisseroto M, Fay AP, Carvalhal GF.

Rev Col Bras Cir. 2018 Nov 29;45(6):e2030. doi: 10.1590/0100-6991e-20182030. Portuguese, English.

14.

Essential factors demonstrating readiness of primary care practices for clinical pharmacy services.

Carrington A, Pokallus A, Ulrich IP, Scott MA, Fay AE, Drake ES, Wilson CG.

Am J Health Syst Pharm. 2018 Nov 1;75(21):1708-1713. doi: 10.2146/ajhp180129.

PMID:
30355599
15.

Clinicopathologic and Magnetic Resonance Imaging Analysis of a Multifocal Orbital Lymphoid Tumor.

Jakobiec FA, Homer N, Zakka FR, Curtin HD, Fay A.

Ocul Oncol Pathol. 2018 Sep;4(2):82-89. doi: 10.1159/000478731. Epub 2017 Aug 23.

16.

Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.

Peek J, Lilic M, Montiel D, Milshteyn A, Woodworth I, Biggins JB, Ternei MA, Calle PY, Danziger M, Warrier T, Saito K, Braffman N, Fay A, Glickman MS, Darst SA, Campbell EA, Brady SF.

Nat Commun. 2018 Oct 8;9(1):4147. doi: 10.1038/s41467-018-06587-2.

17.

Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma.

Hamieh L, Choueiri TK, Ogórek B, Khabibullin D, Rosebrock D, Livitz D, Fay A, Pignon JC, McDermott DF, Agarwal N, Gao W, Signoretti S, Kwiatkowski DJ.

PLoS Genet. 2018 Sep 26;14(9):e1007679. doi: 10.1371/journal.pgen.1007679. eCollection 2018 Sep.

18.
19.

Management of Long-Standing Flaccid Facial Palsy: Periocular Considerations.

Homer N, Fay A.

Otolaryngol Clin North Am. 2018 Dec;51(6):1107-1118. doi: 10.1016/j.otc.2018.07.007. Epub 2018 Aug 28. Review.

PMID:
30170698
20.

Comfortably warm: A momentary lapse of reaffiliation after exclusion.

Fay AJ, Maner JK.

J Exp Psychol Gen. 2018 Aug;147(8):1154-1169. doi: 10.1037/xge0000479.

PMID:
30070576
21.

Care team perspectives on community pharmacy enhanced services.

Fay AE, Ferreri SP, Shepherd G, Lundeen K, Tong GL, Pfeiffenberger T.

J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4S):S83-S88.e3. doi: 10.1016/j.japh.2018.05.009.

PMID:
30006190
22.

Update on the ophthalmic management of facial paralysis.

MacIntosh PW, Fay AM.

Surv Ophthalmol. 2019 Jan - Feb;64(1):79-89. doi: 10.1016/j.survophthal.2018.06.001. Epub 2018 Jun 8. Review.

PMID:
29886125
23.

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma.

McKay RR, Bossé D, Xie W, Wankowicz SAM, Flaifel A, Brandao R, Lalani AA, Martini DJ, Wei XX, Braun DA, Van Allen E, Castellano D, De Velasco G, Wells JC, Heng DY, Fay AP, Schutz FA, Hsu J, Pal SK, Lee JL, Hsieh JJ, Harshman LC, Signoretti S, Motzer RJ, Feldman D, Choueiri TK.

Cancer Immunol Res. 2018 Jul;6(7):758-765. doi: 10.1158/2326-6066.CIR-17-0475. Epub 2018 May 10.

24.

The Ophthalmology Surgical Competency Assessment Rubric (OSCAR) for anterior approach ptosis surgery.

Juniat V, Golnik KC, Bernardini FP, Cetinkaya A, Fay A, Mukherjee B, Pakdel F, Skippen B, Saleh GM.

Orbit. 2018 Dec;37(6):401-404. doi: 10.1080/01676830.2018.1437754. Epub 2018 Feb 14.

PMID:
29442541
25.

Lymphatic malformation with acquired Horner syndrome in an infant.

Spors B, Seemann J, Homer N, Fay A.

J Neurointerv Surg. 2018 Mar;10(3):e2. doi: 10.1136/neurintsurg-2017-013315.rep. Epub 2018 Jan 11.

PMID:
29326377
26.

Poor nighttime sleep is positively associated with dyskinesia in Parkinson's disease patients.

Mao CJ, Yang YP, Chen JP, Wang F, Chen J, Zhang JR, Zhang HJ, Zhuang S, Xiong YT, Gu CC, Yuan W, Huang JY, Fay A, Zhong CK, Liu CF.

Parkinsonism Relat Disord. 2018 Mar;48:68-73. doi: 10.1016/j.parkreldis.2017.12.022. Epub 2017 Dec 21.

27.

Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil.

Bergerot PG, Bergerot CD, Dizman N, Zequi S, Fay A, Dara Y, Maia MC, Cotta BN, Gonçalves EP, Formiga MN, Tariki MS, Clavijo DA, Choueiri TK, Lopes G, Pal SK.

J Glob Oncol. 2018 Sep;4:1-8. doi: 10.1200/JGO.17.00113. Epub 2017 Dec 27.

28.

ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis.

Urun Y, Leow JJ, Fay AP, Albiges L, Choueiri TK, Bellmunt J.

Crit Rev Oncol Hematol. 2017 Dec;120:120-126. doi: 10.1016/j.critrevonc.2017.10.012. Epub 2017 Nov 2. Review.

PMID:
29198325
29.

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.

Moreira RB, Debiasi M, Francini E, Nuzzo PV, Velasco G, Maluf FC, Fay AP, Bellmunt J, Choueiri TK, Schutz FA.

Oncotarget. 2017 Aug 8;8(48):84572-84578. doi: 10.18632/oncotarget.20028. eCollection 2017 Oct 13. Review.

30.

Lymphatic malformation with acquired Horner syndrome in an infant.

Spors B, Seemann J, Homer N, Fay A.

BMJ Case Rep. 2017 Oct 23;2017. pii: bcr-2017-013315. doi: 10.1136/bcr-2017-013315.

31.

Control of biotin biosynthesis in mycobacteria by a pyruvate carboxylase dependent metabolic signal.

Lazar N, Fay A, Nandakumar M, Boyle KE, Xavier J, Rhee K, Glickman MS.

Mol Microbiol. 2017 Dec;106(6):1018-1031. doi: 10.1111/mmi.13865. Epub 2017 Nov 17.

32.

Positive Germline Selection in Pedigrees With Multiple Endocrine Neoplasia Type 2 Carrying V804M Mutation in the RET Gene.

Peddareddygari LR, Fay AM, Shifrin AL, Grewal RP.

World J Oncol. 2016 Dec;7(5-6):104-108. doi: 10.14740/wjon970e. Epub 2016 Dec 23.

33.

Investigation of goldmann perimetry in evaluation of patients for upper eyelid blepharoplasty.

Pemberton JD, Salter M, Fay A, Thuro B, Spencer H, Dajani O.

Orbit. 2018 Feb;37(1):48-52. doi: 10.1080/01676830.2017.1353115. Epub 2017 Aug 16.

PMID:
28812936
34.

Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma.

de Velasco G, Gray KP, Hamieh L, Urun Y, Carol HA, Fay AP, Signoretti S, Kwiatkowski DJ, McDermott DF, Freedman M, Pomerantz MM, Choueiri TK.

Eur Urol Focus. 2016 Dec 15;2(6):633-639. doi: 10.1016/j.euf.2016.03.017. Epub 2016 Apr 23.

35.

Analysis of patient outcomes following proton radiation therapy for retinoblastoma.

Mouw KW, Yeap BY, Caruso P, Fay A, Misra M, Sethi RV, MacDonald SM, Chen YL, Tarbell NJ, Yock TI, Freitag SK, Munzenrider JE, Grabowski E, Katz M, Kuhlthau K, DeCastro D, Heidary G, Ciralsky J, Mukai S, Shih HA.

Adv Radiat Oncol. 2017 Jan-Mar;2(1):44-52. doi: 10.1016/j.adro.2016.11.002.

36.

Running the Numbers: Drug Expenditure Trends in North Carolina Medicaid.

Fay AE, Pfeiffenberger T.

N C Med J. 2017 May-Jun;78(3):208-211. doi: 10.18043/ncm.78.3.208. No abstract available.

37.

Consensus on Diagnostic Criteria of Idiopathic Orbital Inflammation Using a Modified Delphi Approach.

Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, Allen RC, Devoto MH, Harris GJ; Expert Panel of the Orbital Society.

JAMA Ophthalmol. 2017 Jul 1;135(7):769-776. doi: 10.1001/jamaophthalmol.2017.1581.

38.

Genetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological Disease.

Rice GI, Kitabayashi N, Barth M, Briggs TA, Burton ACE, Carpanelli ML, Cerisola AM, Colson C, Dale RC, Danti FR, Darin N, De Azua B, De Giorgis V, De Goede CGL, Desguerre I, De Laet C, Eslahi A, Fahey MC, Fallon P, Fay A, Fazzi E, Gorman MP, Gowrinathan NR, Hully M, Kurian MA, Leboucq N, Lin JS, Lines MA, Mar SS, Maroofian R, Martí-Sanchez L, McCullagh G, Mojarrad M, Narayanan V, Orcesi S, Ortigoza-Escobar JD, Pérez-Dueñas B, Petit F, Ramsey KM, Rasmussen M, Rivier F, Rodríguez-Pombo P, Roubertie A, Stödberg TI, Toosi MB, Toutain A, Uettwiller F, Ulrick N, Vanderver A, Waldman A, Livingston JH, Crow YJ.

Neuropediatrics. 2017 Jun;48(3):166-184. doi: 10.1055/s-0037-1601449. Epub 2017 Apr 10.

39.

Treatment of Leukoencephalopathy With Calcifications and Cysts With Bevacizumab.

Fay AJ, King AA, Shimony JS, Crow YJ, Brunstrom-Hernandez JE.

Pediatr Neurol. 2017 Jun;71:56-59. doi: 10.1016/j.pediatrneurol.2017.03.008. Epub 2017 Mar 23.

40.

One-Stage Supramaximal Full-Thickness Wedge Resection of Vascular Lip Anomalies.

De Castro DK, Ng ZY, Holzer PW, Waner M, Cetrulo CL Jr, Fay A.

J Oral Maxillofac Surg. 2017 Nov;75(11):2449-2455. doi: 10.1016/j.joms.2017.03.020. Epub 2017 Mar 22.

PMID:
28412265
41.

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.

de Velasco G, Culhane AC, Fay AP, Hakimi AA, Voss MH, Tannir NM, Tamboli P, Appleman LJ, Bellmunt J, Kimryn Rathmell W, Albiges L, Hsieh JJ, Heng DY, Signoretti S, Choueiri TK.

Oncologist. 2017 Mar;22(3):286-292. doi: 10.1634/theoncologist.2016-0078. Epub 2017 Feb 20.

42.

Periocular breast carcinoma metastases: correlation of clinical, radiologic and histopathologic features.

Homer N, Jakobiec FA, Stagner A, Cunnane ME, Freitag SK, Fay A, Yoon MK.

Clin Exp Ophthalmol. 2017 Aug;45(6):606-612. doi: 10.1111/ceo.12926. Epub 2017 Mar 3.

PMID:
28181367
43.

Corrigendum: Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.

Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG, Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ.

Nat Genet. 2017 Jan 31;49(2):317. doi: 10.1038/ng0217-317b. No abstract available.

PMID:
28138155
44.

Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA.

Hubin EA, Fay A, Xu C, Bean JM, Saecker RM, Glickman MS, Darst SA, Campbell EA.

Elife. 2017 Jan 9;6. pii: e22520. doi: 10.7554/eLife.22520.

45.

Fulminant type 1 diabetes caused by dual immune checkpoint blockade in metastatic renal cell carcinoma.

Teló GH, Carvalhal GF, Cauduro CGS, Webber VS, Barrios CH, Fay AP.

Ann Oncol. 2017 Jan 1;28(1):191-192. doi: 10.1093/annonc/mdw447. No abstract available.

46.

Reconstitution of a Mycobacterium tuberculosis proteostasis network highlights essential cofactor interactions with chaperone DnaK.

Lupoli TJ, Fay A, Adura C, Glickman MS, Nathan CF.

Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7947-E7956. Epub 2016 Nov 21.

47.

Primary orbital synovial sarcoma: A clinicopathologic review with a differential diagnosis and discussion of molecular genetics.

Stagner AM, Jakobiec FA, Fay A.

Surv Ophthalmol. 2017 Mar - Apr;62(2):227-236. doi: 10.1016/j.survophthal.2016.09.001. Epub 2016 Sep 30. Review.

PMID:
27697479
48.

Natural Variability and Anthropogenic Trends in the Ocean Carbon Sink.

McKinley GA, Fay AR, Lovenduski NS, Pilcher DJ.

Ann Rev Mar Sci. 2017 Jan 3;9:125-150. doi: 10.1146/annurev-marine-010816-060529. Epub 2016 Aug 31.

PMID:
27620831
49.

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

Albiges L, Hakimi AA, Xie W, McKay RR, Simantov R, Lin X, Lee JL, Rini BI, Srinivas S, Bjarnason GA, Ernst S, Wood LA, Vaishamayan UN, Rha SY, Agarwal N, Yuasa T, Pal SK, Bamias A, Zabor EC, Skanderup AJ, Furberg H, Fay AP, de Velasco G, Preston MA, Wilson KM, Cho E, McDermott DF, Signoretti S, Heng DYC, Choueiri TK.

J Clin Oncol. 2016 Oct 20;34(30):3655-3663. doi: 10.1200/JCO.2016.66.7311.

50.

Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.

Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG, Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ.

Nat Genet. 2016 Oct;48(10):1185-92. doi: 10.1038/ng.3661. Epub 2016 Aug 29. Erratum in: Nat Genet. 2017 Jan 31;49(2):317.

Supplemental Content

Support Center